Navigating the HPHA Diagnostic Process
At a Glance
HPHA is diagnosed by matching one-sided Parkinson-like movement symptoms with smaller muscle, tissue, or bone size on the same side, then reviewing early-life history, exam findings, and imaging. No single test confirms it, and MRI or DaTscan may be normal.
Diagnosing Hemiparkinsonism-Hemiatrophy Syndrome (HPHA) is often a process of clinical pattern recognition and exclusion. Because it is so rare, there is no single “gold standard” test that can confirm you have it [1]. Instead, doctors look for a specific pattern: movement symptoms of Parkinson’s disease on the same side of the body that shows smaller muscle, tissue, or bone size (hemiatrophy) [2].
A comprehensive evaluation combines your life history, a detailed physical exam, and potentially specialized brain imaging to piece together the story of your nervous system.
The Importance of Your History
One part of the diagnosis is looking back at your early life. Some researchers hypothesize HPHA could be linked to an event that happened while the brain was still developing [3]. Your doctor may ask about:
- Birth History: Were there complications like hypoxia (lack of oxygen) or a very difficult delivery? [4]
- Early Childhood: Did you have high fevers, a head injury, or a “clumsy” side that you noticed when playing sports as a child? [4][3]
- Symptom Timeline: It is vital to note which came first—the body asymmetry or the movement slowness. In many reported HPHA cases, the asymmetry was present for years before the slowness or tremor began [3].
Advanced Brain Imaging
Imaging is used to look for signs of cerebral hemiatrophy—where one side of the brain is slightly smaller than the other—and to rule out other causes.
Structural MRI
An MRI provides a detailed map of your brain’s anatomy. In HPHA, findings can vary significantly:
- Atrophy Patterns: Some scans show a smaller basal ganglia (a movement control center) or a smaller brainstem on one side [1][5].
- Old Injuries: The scan might reveal signs of an old vascular or structural injury [4].
- Normal Scans: Remarkably, some people with clear HPHA symptoms have an MRI that shows no relevant structural abnormality [3]. A normal scan does not definitively rule out the syndrome; it just means no gross structural cause was detected.
Functional Imaging (DaTscan and PET)
Functional scans are specialist-selected adjuncts.
- DaTscan: This test measures dopamine-transporter binding in the brain. Unlike typical Parkinson’s, where these scans almost always show a loss, HPHA results are inconsistent. Some patients show reduced binding, while others have a completely normal DaTscan despite having clear tremors and stiffness [1][4]. An abnormal result does not specifically confirm HPHA, nor does a normal result confirm it.
- Brain Perfusion: Some specialized PET or perfusion scans might show reduced blood flow to the basal ganglia on the affected side [6], though these are not routinely required.
Diagnostic Evaluation Checklist
A thorough workup for HPHA should involve several steps, tailored to your case:
- [ ] Detailed Neurological Exam: Checking for slowness (bradykinesia), stiffness (rigidity), and assessing reflexes and muscle tone [6][3].
- [ ] Side-by-Side Body Measurements: An objective look at the size of your limbs to document hemiatrophy and distinguish it from disuse [2].
- [ ] High-Resolution Brain MRI: Specifically looking for asymmetry in the brain’s volume, old injury marks, or alternative structural causes [1].
- [ ] Levodopa Challenge: A supervised trial of Parkinson’s medication may be used to see if your symptoms respond. However, response or nonresponse does not prove or exclude idiopathic Parkinson’s disease or HPHA, as dose, duration, and the symptom being measured all matter [1].
- [ ] Screening for “Red Flags”: Ensuring your symptoms aren’t caused by other conditions.
Urgent Symptoms to Report (Red Flags)
Rapid progression or new focal symptoms require timely medical contact rather than being attributed to HPHA automatically. Seek urgent assessment for:
Common questions in this guide
How is hemiparkinsonism-hemiatrophy syndrome diagnosed?
Can an MRI be normal if I have HPHA?
Does a normal DaTscan rule out HPHA?
What does a levodopa challenge show?
Why does my doctor ask about my birth and childhood history?
Which symptoms need urgent medical attention during an HPHA evaluation?
Get notified when new evidence is published on Hemiparkinsonism-hemiatrophy syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Subcortical and brainstem hemiatrophy accompanied by iron deposition in a patient with hemiparkinsonism-hemiatrophy syndrome: a case report.
Chung SJ
BMC neurology 2021; (21(1)):51 doi:10.1186/s12883-021-02080-4.
PMID: 33535984 - 2
Hemiparkinsonism-hemiatrophy syndrome.
Ayromlou H, Najmi S, Arami MA
Archives of Iranian medicine 2011; (14(2)):152-4 doi:011142/AIM.0017.
PMID: 21361726 - 3
Neuropathologic findings in a patient with hemiparkinsonism and hemiatrophy syndrome.
Nakamura M, Tsuge A, Miyake K, et al.
Neuropathology : official journal of the Japanese Society of Neuropathology 2024; (44(6)):432-439 doi:10.1111/neup.12994.
PMID: 38972833 - 4
Hemiparkinsonism or Hemidystonia With Hemiatrophy Syndrome: A Case Series With Follow-Up.
He C, Zhang P, Li Y, et al.
Frontiers in neuroscience 2020; (14()):64 doi:10.3389/fnins.2020.00064.
PMID: 32116511 - 5
Bidirectionality of the dentato-rubro-thalamo-cortical tract allows concurrent hypoperfusion in ipsilateral cerebellum and contralateral cerebral hemisphere: A case report.
He HC, Hsu MC, Hsu CS, et al.
Medicine 2018; (97(40)):e12590 doi:10.1097/MD.0000000000012590.
PMID: 30290625 - 6
[Hemiparkinsonism-Hemiatrophy Syndrome with Hypoperfusion in Basal Ganglia: A Case Report].
Ma B, Wang LH, Zhang YN
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2021; (52(3)):531-533 doi:10.12182/20210560106.
PMID: 34018377 - 7
Acute Post-stroke Hemiparkinsonism and Hemiparesis: A Unique Case with Successful Therapy.
Chandradevan R, Rutkofsky IH, Lynn B, et al.
Cureus 2019; (11(6)):e4950 doi:10.7759/cureus.4950.
PMID: 31453024 - 8
Pediatric Basal Ganglia Region Tumors: Clinical and Radiologic Features Correlated with Histopathologic Findings.
Fu W, Ju Y, Zhang S, You C
World neurosurgery 2017; (103()):504-516 doi:10.1016/j.wneu.2017.04.004.
PMID: 28408259
This page is for informational purposes only and does not constitute medical advice. A neurologist should interpret your HPHA history, examination, imaging, and medication-trial results.